Logo of wtpaEurope PMCEurope PMC Funders GroupSubmit a Manuscript
PMC full text:
Nature. Author manuscript; available in PMC 2021 Feb 17.
Published in final edited form as:
Nature. 2020 Nov 1; 587(7835): 657–662.
Published online 2020 Jul 29. doi: 10.1038/s41586-020-2601-5

Extended Data Fig. 7

An external file that holds a picture, illustration, etc.
Object name is EMS114568-f012.jpg
Inhibitory effects of GRL-0617 on SARS-CoV2 infection.

a, Intracellular virus production was analysed by PCR targeting SARS-CoV-2 RdRP mRNA. Relative expression level of SARS-CoV2-2 genomic RNA was normalized to cellular GAPDH level. b, Intracellular RNA was isolated from cells without infection or cells infected with SARS-CoV-2 with or without treatment of GRL-0617. Relative mRNA-level fold change of indicated genes were analysed in a qRT–PCR analysis and normalized to ACTB levels. Data in a, b are presented as mean ± s.d. (n = 3, independent experiments). *P < 0.05, **P < 0.01; two-tailed paired t-tests. c, Schematic representation of the role of SARS-CoV-2 PLpro in the viral life cycle. The physiological role of SCoV2-PLpro in both host-immune response and polypeptide processing is shown. Inhibition of PLpro by GRL-0617 is also presented.

Images in this article

  • Fig. 1
  • Fig. 2
  • Fig. 3
  • Fig. 4
  • Fig. 5

Click on the image to see a larger version.

-